homovanillic acid has been researched along with Movement Disorders in 54 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ventricular fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), the respective metabolites of dopamine and serotonin, were measured in 57 patients undergoing thalamotomy for relief of movement disorders." | 7.66 | Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. ( Sharpless, NS; Tabaddor, K; Wolfson, LI, 1978) |
| "Two cases of severe dystonia and dyskinesia were treated with talipexole, a dopamine autoreceptor agonist, and the metabolites of dopamine, norepinephrine, and serotonin in cerebrospinal fluid (CSF) were determined." | 3.68 | Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans. ( Koga, I; Nishikawa, T; Tanaka, M; Tsuda, A; Uchida, Y; Yamada, S, 1990) |
| "Ventricular fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA), the respective metabolites of dopamine and serotonin, were measured in 57 patients undergoing thalamotomy for relief of movement disorders." | 3.66 | Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. ( Sharpless, NS; Tabaddor, K; Wolfson, LI, 1978) |
| "We have studied the urinary excretion of 1,4-methylhistamine (1,4-MeHm), 5-hydroxyindole-3-acetic acid (5-HIAA) and homovanillic acid (HVA) in patients with Parkinson's disease, choreiform movements and essential tremor." | 3.65 | Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa. ( Fleming, AM; Lenman, JA; Reid, A; Turnbull, MJ, 1977) |
| "Haloperidol is a classical neuroleptic drug that is still in use and can lead to abnormal motor activity such as tardive dyskinesia (TD) following repeated administration." | 1.35 | Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2008) |
| "In contrast to senile dementia of Alzheimer's type SLI was not correlated with dementia scores but with motor disease progression." | 1.28 | Parkinson's disease and dementia: clinical and neurochemical correlations. ( Cramer, H; Strittmatter, MM, 1992) |
| "Treatment with tetrabenazine did not significantly alter the metabolite levels in patients in whom it produced either improvement, or side effects." | 1.26 | CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. ( Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (64.81) | 18.7374 |
| 1990's | 7 (12.96) | 18.2507 |
| 2000's | 6 (11.11) | 29.6817 |
| 2010's | 5 (9.26) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Wong, RSH | 1 |
| Mohammad, S | 1 |
| Parayil Sankaran, B | 1 |
| Junek, R | 1 |
| Kim, WT | 1 |
| Wotton, T | 1 |
| Devanapalli, B | 1 |
| Bandodkar, S | 1 |
| Balasubramaniam, S | 1 |
| Papandreou, A | 1 |
| Rahman, S | 1 |
| Fratter, C | 1 |
| Ng, J | 1 |
| Meyer, E | 1 |
| Carr, LJ | 1 |
| Champion, M | 1 |
| Clarke, A | 1 |
| Gissen, P | 1 |
| Hemingway, C | 1 |
| Hussain, N | 1 |
| Jayawant, S | 1 |
| King, MD | 1 |
| Lynch, BJ | 1 |
| Mewasingh, L | 1 |
| Patel, J | 1 |
| Prabhakar, P | 1 |
| Neergheen, V | 1 |
| Pope, S | 1 |
| Heales, SJR | 1 |
| Poulton, J | 1 |
| Kurian, MA | 1 |
| Willard, AM | 1 |
| Bouchard, RS | 1 |
| Gittis, AH | 1 |
| Batool, F | 1 |
| Shah, AH | 1 |
| Ahmed, SD | 1 |
| Saify, ZS | 1 |
| Haleem, DJ | 1 |
| Ormazabal, A | 1 |
| Serrano, M | 1 |
| Garcia-Cazorla, A | 1 |
| Campistol, J | 1 |
| Artuch, R | 1 |
| Castro de Castro, P | 1 |
| Barredo-Valderrama, E | 1 |
| Armstrong, J | 1 |
| Toma, C | 1 |
| Cormand, B | 1 |
| Morelli, E | 1 |
| Moore, H | 1 |
| Rebello, TJ | 1 |
| Gray, N | 1 |
| Steele, K | 1 |
| Esposito, E | 1 |
| Gingrich, JA | 1 |
| Ansorge, MS | 1 |
| Kato, H | 1 |
| Kurosaki, R | 1 |
| Oki, C | 1 |
| Araki, T | 1 |
| Zhao, Y | 1 |
| DeCuypere, M | 1 |
| LeDoux, MS | 1 |
| Bishnoi, M | 1 |
| Chopra, K | 1 |
| Kulkarni, SK | 1 |
| Becker, RE | 1 |
| Lal, H | 1 |
| Jeste, DV | 1 |
| Doongaji, DR | 1 |
| Linnoila, M | 1 |
| Gil-Nagel, A | 1 |
| Morlán, L | 1 |
| Balseiro, J | 1 |
| García de Yébenes, J | 1 |
| Cabello, A | 1 |
| Martínez-Martín, P | 1 |
| Fall, PA | 1 |
| Ekman, R | 1 |
| Granérus, AK | 1 |
| Thorell, LH | 1 |
| Wålinder, J | 1 |
| Paul, G | 1 |
| Reum, T | 1 |
| Meissner, W | 1 |
| Marburger, A | 1 |
| Sohr, R | 1 |
| Morgenstern, R | 1 |
| Kupsch, A | 1 |
| Hyland, K | 1 |
| Beaman, BL | 1 |
| LeWitt, PA | 1 |
| DeMaggio, AJ | 1 |
| Goettl, VM | 1 |
| Wemlinger, TA | 1 |
| Colvin, AE | 1 |
| Neff, NH | 1 |
| Hadjiconstantinou, M | 1 |
| Moskowitz, MA | 1 |
| Wurtman, RJ | 1 |
| Klawans, H | 1 |
| Tabaddor, K | 1 |
| Wolfson, LI | 1 |
| Sharpless, NS | 1 |
| Wood, JH | 1 |
| Davidson, DL | 1 |
| Yates, CM | 1 |
| Mawdsley, C | 1 |
| Pullar, IA | 1 |
| Wilson, H | 1 |
| Price, KS | 1 |
| Farley, IJ | 1 |
| Hornykiewicz, O | 1 |
| Rinne, UK | 1 |
| Siirtola, T | 1 |
| Sonninen, V | 1 |
| Lenman, JA | 1 |
| Turnbull, MJ | 1 |
| Reid, A | 1 |
| Fleming, AM | 1 |
| Rosenberg, RN | 1 |
| Nyhan, WL | 1 |
| Bay, C | 1 |
| Shore, P | 1 |
| Klawans, HL | 1 |
| Moses, H | 1 |
| Nausieda, PA | 1 |
| Bergen, D | 1 |
| Weiner, WJ | 1 |
| Gerlach, J | 1 |
| Thorsen, K | 1 |
| Fog, R | 1 |
| Sayers, AC | 1 |
| Bürki, HR | 1 |
| Ruch, W | 1 |
| Asper, H | 1 |
| García Ruiz, PJ | 1 |
| Mena, MA | 1 |
| Peñafiel, N | 1 |
| De Yébenes, JG | 1 |
| Strittmatter, MM | 1 |
| Cramer, H | 2 |
| Nishikawa, T | 1 |
| Yamada, S | 1 |
| Tsuda, A | 1 |
| Tanaka, M | 1 |
| Koga, I | 1 |
| Uchida, Y | 1 |
| Dávila, R | 1 |
| Andía, I | 1 |
| Miller, JC | 1 |
| Friedhoff, AJ | 1 |
| Guimón, J | 1 |
| Ahlskog, JE | 1 |
| Kelly, PJ | 1 |
| van Heerden, JA | 1 |
| Stoddard, SL | 1 |
| Tyce, GM | 1 |
| Windebank, AJ | 1 |
| Bailey, PA | 1 |
| Bell, GN | 1 |
| Blexrud, MD | 1 |
| Carmichael, SW | 1 |
| Yamamoto, M | 1 |
| Ujike, H | 1 |
| Ogawa, N | 1 |
| Bradbury, AJ | 2 |
| Costall, B | 2 |
| Domeney, AM | 2 |
| Testa, B | 1 |
| Jenner, PG | 1 |
| Marsden, CD | 3 |
| Naylor, RJ | 2 |
| Jenner, PJ | 1 |
| Jankovic, J | 1 |
| Caskey, TC | 1 |
| Stout, JT | 1 |
| Butler, IJ | 1 |
| Kostic, V | 1 |
| Djuricic, B | 1 |
| Paschen, W | 1 |
| Birkmayer, W | 1 |
| Birkmayer, GJ | 1 |
| Vrecko, K | 1 |
| Mlekusch, W | 1 |
| Paletta, B | 1 |
| Ott, E | 1 |
| Cross, AJ | 1 |
| Crow, TJ | 1 |
| Ferrier, IN | 1 |
| Johnson, JA | 1 |
| Johnstone, EC | 1 |
| Owen, F | 1 |
| Owens, DG | 1 |
| Poulter, M | 1 |
| Kurlan, R | 1 |
| Goldblatt, D | 1 |
| Zaczek, R | 1 |
| Jeffries, K | 1 |
| Irvine, C | 1 |
| Coyle, J | 1 |
| Shoulson, I | 1 |
| Dill, RE | 1 |
| Campbell, KM | 1 |
| Messiha, FS | 2 |
| Constantinidis, J | 1 |
| Curzon, G | 2 |
| Ng, LK | 1 |
| Chase, TN | 1 |
| Cohen, DJ | 1 |
| Shaywitz, BA | 1 |
| Johnson, WT | 1 |
| Bowers, M | 1 |
| Sweet, RD | 1 |
| McDowell, FH | 1 |
| Guilleminault, C | 1 |
| Tharp, BR | 1 |
| Cousin, D | 1 |
| Barbeau, A | 1 |
| Lhermitte, F | 1 |
| Rosa, A | 1 |
| Comoy, E | 1 |
| Bohuon, C | 1 |
| Parkes, JD | 1 |
| Rees, JE | 1 |
| Kantamaneni, BD | 1 |
| Knill-Jones, R | 1 |
| Akbar, A | 1 |
| Das, S | 1 |
| Kataria, M | 1 |
| Fahn, S | 1 |
4 reviews available for homovanillic acid and Movement Disorders
| Article | Year |
|---|---|
Pharmacological approaches to treatment of hemiballism and hemichorea.
Topics: Acetylcholine; Antipsychotic Agents; Basal Ganglia; Cerebrovascular Disorders; Chorea; Diazepam; Dop | 1983 |
Catecholamines and neurologic diseases (second of two parts).
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cereb | 1975 |
Amine precursors in neurologic disorders and the psychoses.
Topics: Acetylcholine; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindo | 1975 |
[Biochemical and clinical correlations in Parkinson's disease].
Topics: Brain; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Humans; Movement Disorders; Norepinephri | 1972 |
1 trial available for homovanillic acid and Movement Disorders
| Article | Year |
|---|---|
Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients.
Topics: Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Clozapine; Dibenzazepines; Haloperido | 1975 |
49 other studies available for homovanillic acid and Movement Disorders
| Article | Year |
|---|---|
Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.
Topics: Autism Spectrum Disorder; Biopterins; Homovanillic Acid; Humans; Infant, Newborn; Male; Movement Dis | 2023 |
Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease.
Topics: Adolescent; Child; Child, Preschool; DNA Polymerase gamma; Female; Homovanillic Acid; Humans; Hydrox | 2018 |
Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Chromatography, High Pressure Liquid; Di | 2015 |
Protective effects of aqueous fruit extract from Sea Buckthorn (Hippophae rhamnoides L. Spp. Turkestanica) on haloperidol-induced orofacial dyskinesia and neuronal alterations in the striatum.
Topics: Administration, Oral; Animals; Catalepsy; Dopamine; Exploratory Behavior; Fruit; Haloperidol; Hippop | 2010 |
Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
Topics: Antiparkinson Agents; Carbidopa; DNA Mutational Analysis; Drug Combinations; Female; Homovanillic Ac | 2011 |
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Animals, Newborn; Basal Ganglia; Cell Count; C | 2011 |
Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Cell Communication; Dopamine; Glial | 2004 |
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.
Topics: Animals; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Gene Deletion; Hind | 2008 |
Protective effect of L-type calcium channel blockers against haloperidol-induced orofacial dyskinesia: a behavioural, biochemical and neurochemical study.
Topics: Animals; Antioxidants; Antipsychotic Agents; Behavior, Animal; Calcium Channel Blockers; Calcium Cha | 2008 |
Elevated cerebrospinal fluid noradrenaline in tardive dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Homovan | 1984 |
[Neuro-acanthocytosis with associated myopathy. A case report].
Topics: Acanthocytes; Adult; Basal Ganglia; Basophils; Brain Diseases; Cerebellum; Denervation; Homovanillic | 1994 |
ECT in Parkinson's disease. Changes in motor symptoms, monoamine metabolites and neuropeptides.
Topics: Aged; Aged, 80 and over; Biogenic Monoamines; Electroconvulsive Therapy; Female; Homovanillic Acid; | 1995 |
High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Electric Stimulation; Extracellu | 2000 |
Monoamine changes in the brain of BALB/c mice following sub-lethal infection with Nocardia asteroides (GUH-2).
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cerebellum; Dopamine; Female; H | 2000 |
Motoric behavior in aged rats treated with GM1.
Topics: Aging; Animals; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Male; Motor Activity; Movement Disor | 2001 |
Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
Topics: Adult; Aged; Cerebral Palsy; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Middle A | 1978 |
CSF HVA and 5-HIAA.
Topics: Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Movement Disorders; Phenylacetates | 1979 |
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.
Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; | 1977 |
Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine.
Topics: Affective Symptoms; Caudate Nucleus; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Limbic Sy | 1978 |
L-deprenyl treatment of on-off phenomena in Parkinson's disease.
Topics: Aged; Benserazide; Dopamine; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyin | 1978 |
Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa.
Topics: Amantadine; Chorea; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methylhistamines; | 1977 |
Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder.
Topics: Adult; Aged; Brain Diseases; Caudate Nucleus; Cerebellar Nuclei; Corpus Striatum; Eye Movements; Fem | 1976 |
Treatment and prognosis of hemiballismus.
Topics: Acute Disease; Aged; Chlorpromazine; Diencephalon; Dopamine; Feedback; Female; Haloperidol; Homovani | 1976 |
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; | 1975 |
Cinnarizine-induced parkinsonism in primates.
Topics: Animals; Biogenic Monoamines; Cinnarizine; Disease Models, Animal; Dopamine; Haplorhini; Homovanilli | 1992 |
Parkinson's disease and dementia: clinical and neurochemical correlations.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic A | 1992 |
Chronic treatment with talipexole dihydrochloride on abnormal involuntary movement in humans.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Azepines; Dopamine Agents; Dystonia; Homovanillic Acid; Humans | 1990 |
Evidence of low dopaminergic activity in elderly women with spontaneous orofacial dyskinesia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Dopamine; Estradiol; Facial Muscles; Female | 1991 |
Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies.
Topics: Activities of Daily Living; Adrenal Medulla; Adult; Caudate Nucleus; Cells, Cultured; Dopamine; Epin | 1990 |
Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
Topics: Droxidopa; Electromyography; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydro | 1985 |
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic | 1985 |
The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic | 1986 |
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.
Topics: Carbidopa; Catecholamines; Child; Child, Preschool; Fluphenazine; Glycols; Homovanillic Acid; Humans | 1988 |
Hemiballismus: changes in cerebrospinal fluid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Dominance, Cerebral; Dopamine; Female; Homovanillic Acid; Huma | 1988 |
The coenzyme nicotinamide adenine dinucleotide (NADH) improves the disability of parkinsonian patients.
Topics: Aged; Aged, 80 and over; Homovanillic Acid; Humans; Injections, Intravenous; Middle Aged; Movement D | 1989 |
Chemical and structural changes in the brain in patients with movement disorder.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Antipsychotic Agents; Brain; Choline O-Acetyltransfer | 1985 |
Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
Topics: Adult; Homovanillic Acid; Humans; Huntington Disease; Middle Aged; Movement Disorders; Parkinson Dis | 1988 |
3 methoxytyramine: a possible endogenous toxin of psychosis?
Topics: Animals; Corpus Striatum; Dose-Response Relationship, Drug; Haplorhini; Homovanillic Acid; Humans; M | 1973 |
A study of biogenic amine metabolites in the cerebrospinal fluid and urine of monkeys with chlorpromazine-induced dyskinesia.
Topics: 5-Methoxytryptamine; Animals; Biogenic Amines; Chlorpromazine; Dopamine; Epinephrine; Female; Haplor | 1974 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus | 1972 |
Involuntary movements other than Parkinsonism: biochemical aspects.
Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic | 1973 |
Adenosine 3',5'-monophosphate in cerebrospinal fluid. Effect of drugs and neurologic disease.
Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Child; Cyclic AMP; Dihydroxyphenylalanine; Female; Hom | 1973 |
The relationship of dopamine excretion to chlorpromazine-induced dyskinesia in monkeys.
Topics: Administration, Intranasal; Animals; Chlorpromazine; Dopamine; Homovanillic Acid; Intubation; Macaca | 1974 |
Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
Topics: Autistic Disorder; Brain; Child; Child, Preschool; Diagnosis, Differential; Dopamine; Electroencepha | 1974 |
Plasma dopa concentrations and the "on-off" effect after chronic treatment of Parkinson's disease.
Topics: Dietary Proteins; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levod | 1974 |
HVA and 5HIAA CSF measurements and 5HTP trials in some patients with involuntary movements.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Chorea; Dopamine; Dystonia Musculorum Deformans; Femal | 1973 |
[Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
Topics: Benzoates; Dihydroxyphenylalanine; Dopamine; Electrocoagulation; Female; Homovanillic Acid; Humans; | 1973 |
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa.
Topics: Aged; Dementia; Dihydroxyphenylalanine; Electroencephalography; Female; Gait; Homovanillic Acid; Hum | 1974 |
"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
Topics: Adult; Carbidopa; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Homov | 1974 |